X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

SCHOTT teams up with SINCAD to ensure the highest quality pharmaceutical packaging

Content Team by Content Team
30th April 2019
in Manufacturing, Packaging & Logistic, Press Statements
SCHOTT pharmaceutical packaging

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Pharma Packaging division signs exclusive cooperation and development agreement with French engineering company that specializes in developing and manufacturing vision control systems

The international technology group SCHOTT and the French engineering firm SINCAD have signed an exclusive cooperation and development agreement aimed at strengthening SCHOTT’s expertise in the field of camera inspection systems. The agreement includes the assurance that SINCAD will distribute its highly advanced camera systems exclusively to SCHOTT and not offer them to any other supplier in the pharmaceutical industry in the future.

To manufacture its high-quality packaging for the pharmaceutical industry, including state-of-the-art ampoules, vials, cartridges and syringes, SCHOTT relies on the most advanced camera systems to inspect and ensure the quality of each individual product. The cameras measure the accuracy of the geometry as well as other important parameters. The vision control systems from SINCAD are used to ensure the appearance, dimensional accuracy, color, and 3D laser profile.

“We have been working with SINCAD for some time now and greatly appreciate their extremely reliable systems. This cooperation now exclusively binds this excellent supplier of vision control camera systems to us,” says Christoph Döppes, Project Director New Production Concept Vials, Global Operations at SCHOTT. “We plan to share our mutual know-how in order to learn from each other, make our products even better, and develop better camera systems in the future.” This will also involve artificial intelligence, an area that SCHOTT has been strategically investing in most recently. For instance, the camera systems will be shown images of defective products so they can independently learn to recognize even the most minor defects in the products manufactured.

About SINCAD
SINCAD is an engineering company that specializes in designing and manufacturing vision control systems that cover the following areas: appearance control, dimensional control, colorimetric control, presence control and 3D laser profile control.

About SCHOTT
SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. With more than 15,500 employees at production sites and sales offices in 34 countries, the group has a global presence. In the 2017/2018 fiscal year, SCHOTT generated sales of 2.08 billion euros. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. This is one of the oldest private and one of the largest science-promoting foundations in Germany. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment.

Previous Post

On-Metal RFID tags enable 100% retail inventory tagging

Next Post

Interphex Annual CONFERENCE celebrates 40 years of Excellence in Pharmaceutical and Biotechnology Innovation

Related Posts

FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Insights

Green Chemistry in Sustainable API Manufacturing

26th September 2025
active pharmaceutical ingredients supply chain
Drug Development

Future of Active Pharmaceutical Ingredients Supply

26th September 2025
pharmaceutical excipients for new therapies
Drug Development

Advances in Pharmaceutical Excipients for New Therapies

26th September 2025
Next Post
Interphex 2019

Interphex Annual CONFERENCE celebrates 40 years of Excellence in Pharmaceutical and Biotechnology Innovation

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In